[64] identified three CpGs which were only identified in PD patients as opposed to the controls which were associated with organophosphate exposure including cg03329597 (MYH15), cg15600437 (MFAP2) and cg18433519 (KIAA0319). Here, MYH15 is linked to Parkinson disease.